NorthWest Biotherapeutics Inc (NWBO)

[Horseb4CarT]

There has been multiple forces at work against the success of nwbo for over a decade, and they have had detrimental impacts. Some impacts include being forced to keep raising funds in unfavorable manners and lower share prices.

In order to survive we wound up on the OTC market, which precludes many investment funds from investing, and is a market full of shenanigans by the big dogs of the market.

I have no doubt that given the concrete factual progress that has been achieved, and sitting with a successful phase 3 where every one of the hundreds of previous trials have failed, and at the doorstep of first approval, the share price would be north of $10 by now.

However the real news is spreading and with first approval the treatment, company, and share price, will all begin to reflect true value potential. I say potential because while we have a handle on the GBM market, this is only the beginning and the tip of the huge iceberg of solid tumor cancer indications and potentially non cancer diseases.

So the current share price is not representative of nwbo’s value and imminent impact on the oncology world!